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Evidence for early nasogastric tube removal after
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Yann Gouëffic, MD,a Bertrand Rozec, MD,b Alice Sonnard, MD,b Philippe Patra, MD,a
and Yvonnick Blanloeil, MD,b Nantes, France
Objective: Nasogastric tube (NGT) decompression after abdominal surgery is still largely used to prevent nausea and
vomiting. However, indications are based more on practice than on studies. Moreover, prolonged NGT decompression
can lead to complications. In this prospective and randomized study, we evaluated the effects of early withdrawal of NGTs
in patients undergoing surgery of the infrarenal aorta.
Methods: Between October 2001 and May 2002, consecutive patients underwent scheduled infrarenal aortic operations.
Patients were prospectively randomised into two groups: group 1, NGT maintenance until the passage of flatus; and
group 2, NGT removal at the time of tracheal extubation. Preoperative and perioperative data were collected. The main
end point was the occurrence of nausea and vomiting. Secondary end points were tolerance of NGT withdrawal and
postoperative complications. Criteria were compared between groups by using Mann-Whitney or Fisher exact tests.
Results: Forty-six patients underwent aortic operations. Six patients were subsequently excluded from the study. Of the
40 randomized subjects, 20 patients were included in each group. Preoperative and intraoperative data were similar in
both groups. There was no statistical difference between groups regarding nausea and vomiting. In group 1, the
occurrence of respiratory complications was more frequent compared with group 2 (5 vs 0 complications; P  .023).
There was no significant difference in intensive care unit stay, but the hospital stay was shorter in group 2 (mean, 9  3
days vs 15  9 days; P  .016). There were no differences in other adverse events.
Conclusions: This study does not support a significant effect of early removal of NGTs on nausea and vomiting in patients
undergoing open repair of the infrarenal aorta. However, these findings suggest that NGT maintenance increases the risk
of respiratory complications and the length of hospital stay. ( J Vasc Surg 2005;42:654-9.)During the last 20 years, patients undergoing infrarenal
aortic surgery have benefited from a significant reduction of
perioperative morbidity and mortality.1,2 The development
of new surgical techniques and the improvement of periop-
erative management explain this phenomenon. However,
certain treatment strategies are not based on studies, but
rather on routine practices.
The postoperative course of abdominal laparotomy is
marked by an inhibition of coordinated bowel activity,
which causes an accumulation of secretions and results in
digestive discomfort, abdominal distension, nausea, vomit-
ing, and a stop of flatus per the rectum.3 Postoperative ileus
can develop after all types of abdominal surgery, including
extraperitoneal surgery.4 The accumulation of digestive
secretions and air in the digestive tract can be responsible
for wound dehiscence and negative interactions with respi-
ratory function.5,6 Treatment of postoperative ileus in-
cludes different types of resuscitation, such as correction of
electrolyte disorders or nasogastric decompression. The
initial purpose of nasogastric tube (NGT) use is to decom-
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654press the bowel after bowel resection and thereby reduce
postoperative complications such as wound dehiscence,
anastomotic disruption, aspiration, and wound infection.6
Usually, an NGT is placed just after the induction of anesthe-
sia and is maintained until the reappearance of passage of flatus
per the rectum, at which point it is removed.
In 2002, to assess NGT use in France, we sent a
questionnaire to 500 vascular surgeons (database from the
Collège Français de Chirurgie Vasculaire). Vascular sur-
geons were asked to describe their NGT use during aortic
operations. Among 252 responses, 10 (4%) did not men-
tion their NGT use, 163 (65%) kept an NGT until resump-
tion of intestinal function, 72 (28%) preferred early NGT
removal, and 7 (3%) did not use an NGT during the
perioperative period.
However, little scientific evidence supports the main-
tenance of NGT after laparotomy. A meta-analysis of
selective routine nasogastric decompression after elective
laparotomy for gastrointestinal and gynecologic surgery
showed that a shortened NGT decompression was not
associated with severe complications such as respiratory
complications or anastomotic leaks.5 However, NGTs
could increase postoperative discomfort and the incidence
of aspiration pneumonia and atelectasis.7 Only one study
has evaluated NGT withdrawal for aortic surgery.8 This
study showed no benefit for NGTmaintenance, but neither
postoperative nausea nor postoperative vomiting was an
end point. These data led us to question the systematic
need for gastrointestinal decompression via NGT after
infrarenal aortic surgery.
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ened nasogastric decompression vs routine nasogastric de-
compression after open infrarenal aortic surgery. The oc-
currence of postoperative nausea and vomiting (PONV)
was the main end point.
PATIENTS AND METHODS
Between October 2001 and May 2002, consecutive
patients referred to the University Hospital of Nantes un-
derwent scheduled infrarenal aortic operations to treat
abdominal aortic aneurysms or aortoiliac occlusive disease.
This prospective and randomized study was approved by the
local ethics committee (Comité Consultatif de Protection des
Personnes dans la Recherche Biomédicale), and informed
consent was obtained from each patient. Patients included in
this study were older than 18 years of age. Excluded from
this study were patients with previous esophagogastric or
pancreatoduodenal surgery; gastroesophageal reflux, hiatal
hernia, or both; swallowing difficulties; PONV; emergent
surgery (ruptured abdominal aortic aneurysm); lack of pre-
operative bowel preparation; retroperitoneal approach; ac-
cidental intraoperative bowel injury; adhesiolysis for more
than 1 hour; epidural anesthesia or analgesia; inhaled anes-
thetic use; intraoperative or postoperative metabolic distur-
bance (severe acidosis or hypokalemia); postoperative me-
chanical ventilation requirement for longer than 12 hours;
or postoperative consciousness disorders (Glasgow score
10). Conventional techniques for open abdominal aortic
surgery with a midline or transverse transperitoneal ap-
proach were used with evisceration in each case. A retractor
was then gently placed to prevent the small bowel from
entering the operating field.
Anesthetic protocol. A standardized protocol was
used, to reduce bias. All patients underwent bowel prepa-
ration in the hypothesis of elective colonic surgery due to
colonic necrosis after aortic surgery. Antibiotic prophylaxis
was performed with cefazolin, cefuroxime, or vancomycin.
Systemic heparin anticoagulation (50 U/kg) was intrave-
nously administered at the time of cross-clamping. Hyp-
notics used for the induction of general anesthesia were
propofol or etomidate, whereas thiopental was prohibited.
Sufentanil was the only opioid used. Atracurium or cisatra-
curium was chosen as a muscle relaxant. Maintenance of
anesthesia was obtained by associating propofol, sufentanil,
and atracurium or cisatracurium. Authorized intraoperative
treatments were hypotensive drugs (nicardipine or urapi-
dil), vasopressors (ephedrine or norepinephrine), and ino-
tropic drugs (dobutamine or dopexamine). Volume re-
placement was performed by crystalloids, colloids (gelatin
or hydroxyethyl starch), or blood products. An NGT was
placed after anesthetic induction, and its position was con-
trolled surgically.
Postoperative follow-up. All patients were admitted
to the surgical intensive care unit, where the NGT was
removed or not at the time of tracheal extubation. Patients
were prospectively randomized into group 1 (NGT main-
tenance until the passage of flatus) or group 2 (NGT
removal at the time of tracheal extubation). During post-operative care, mean blood pressure was maintained be-
tween 90 and 110 mm Hg by using the intraoperative
authorized treatment if necessary. For all groups, the fol-
lowing analgesic protocol was used: propacetamol (2 g/6 h
intravenously) and intravenous morphine patient-con-
trolled analgesia (1-mg bolus with a 7- to 15-minute lock-
out interval). Ulcer prevention was performed with hista-
mine H2-receptor antagonists. In case of nausea, vomiting,
or both, dolasetron (12.5 mg intravenously) was used. If
this failed (vomiting persisted for 10 minutes after infusion
or was severe), then the NGT was replaced.
End points. The main end point was the occurrence
of PONV. Secondary end points were passage of flatus per
rectum, tolerance of NGT removal or maintenance, and
postoperative complications. Baseline clinical characteris-
tics and intraoperative data were collected in a computer-
ized database.
Statistical analysis. End points were expressed as ab-
solute values or percentages. Other data were expressed as
mean SD. Statistical analysis used theMann-Whitney test
for non normally distributed continuous variables and the
Fisher exact test for categorical data. P  .05 was consid-
ered significant.
RESULTS
The study population consisted of 46 consecutive pa-
tients undergoing open operation of the infrarenal aorta
between October 2001 and May 2002. Among them, six
patients were excluded because of emergent surgery (three
patients), gastroesophageal reflux (one patient), request for
Table I. Baseline clinical characteristics
Variable
Group 1
(n  20)*
Group 2
(n  20)†
Age, y (mean  SD) 66.4  11.1 63.9  9.4
Sex ratio (M/F) 18/2 19/1
BMI, kg/m2 (mean  SD) 25.3  4.0 27.1  3.6
BMI 27 kg/m2 7 (35%) 12 (60%)
Dyslipidemia 13 (65%) 11 (55%)
Hypertension 15 (75%) 13 (65%)
Smoker 16 (80%) 17 (85%)
Diabetes 1 (5%) 0
Coronary artery disease 11 (55%) 6 (30%)
COPD 5 (25%) 3 (15%)
Arterial occlusive disease 11 (55%) 11 (55%)
Stroke 2 (10%) 1 (5%)
Heart failure 3 (15%) 1 (5%)
Alcohol abuse 6 (30%) 3 (15%)
Laparotomy history 7 (35%) 5 (25%)
Aortic pathology
AOD 10 (50%) 10 (50%)
Aneurysm 10 (50%) 10 (50%)
Aneurysm diameter, mm
(mean  SD) 54  5 60  10
BMI, Body mass index; COPD, chronic obstructive pulmonary disease;
AOD, aortoiliac occlusive disease.
Data are n (%) unless otherwise noted.
*Group 1 included patients with prolonged gastric decompression.
†Group 2 included patients with early removal of the nasogastric tube.epidural analgesia (one patient), and requirement for post-
JOURNAL OF VASCULAR SURGERY
October 2005656 Gouëffic et aloperative mechanical ventilation for more than 12 hours
(one patient). Surgical repairs included 20 aortic aneurysms
and 20 aortoiliac occlusive diseases. The two groups were
well matched for baseline clinical characteristics (Table I).
Nine and seven patients had a previous history of laparot-
omy in groups 1 and 2, respectively. The distribution of
abdominal aortic aneurysm or aortoiliac occlusive disease
operations was not different between groups. The mean
aneurysm diameter was equivalent in the compared groups.
Intraoperative data were similar in both groups (Table II).
Complete follow-up data and treatment assignment
were available for all patients (Table III). The vomiting
incidence rate was 10% (n 2) in group 2. One patient had
vomiting associated with diarrhea 2 days after surgery.
Endoscopic investigations did not reveal any digestive eti-
ology. Symptoms resolved spontaneously. For the second
patient, the operative course was characterized by major
bleeding (3400 mL) and cardiovascular instability. Vomit-
Table II. Intraoperative data according to removal of the
Variable
Operation duration, min (mean  SD)
Cross-clamping duration, min (mean  SD)
Cross-clamping type
Infrarenal
Interrenal
Suprarenal
Intraoperative blood loss, mL (mean  SD)
Temperature at the end of the procedure, °C (mean  SD)
Data are n (%) unless otherwise noted.
*Group 1 included patients with prolonged gastric decompression.
†Group 2 included patients with early removal of the nasogastric tube.
Table III. Postoperative data
Variable Grou
Vomiting
Nausea
Tube replacement
Morphine consumption, mg/d (mean  SD)
Day of operation 12
First day after operation 23
Second day after operation 8
SAPS II 20
Morbidity
Respiratory complications
Laryngeal trauma
Atrial fibrillation
Hematemesis
Functional renal failure
Mortality
Reintervention
Length of ICU stay, d (mean  SD) 4
Length of hospital stay, d (mean  SD)
NS, Not significant; SAPS II, simplified acute physiology score; ICU, inten
Data are n (%) unless otherwise noted.
*Group 1 included patients with prolonged gastric decompression.
†Group 2 included patients with early removal of the nasogastric tube.ing occurred immediately after tracheal extubation, al-though hemodynamic variables were stabilized. No tube
replacement was necessary. No difference in vomiting was
observed between groups. In group 1, one patient had an
isolated vomiting episode after refeeding, with spontane-
ous resolution. The other two patients were a woman with
NGT intolerance and an obese man. In both cases, despite
early passage of flatus and tube removal, resistant vomiting
after medical treatment occurred, and nasogastric decom-
pression was reintroduced for 48 hours.
Nausea rates were comparable in both groups. In addi-
tion, the tube-replacement rate, morphine consumption,
and resumption of flatus were equivalent in both groups
(Fig 1 and Table III). In our trial, three patients had serious
complications. The first patient had serious pneumonia that
required reintubation 8 hours after extubation. The iden-
tified germ was methicillin-resistant Staphylococcus aureus
and, considering the early symptoms, was probably related
to two previous hospitalizations in the intensive care unit.
gastric tube
Group 1 (n  20)* Group 2 (n  20)†
177  58 179  67
62  21 68  32
18 (90%) 16 (80%)
0 1 (5%)
2 (10%) 3 (15%)
1488  855 1324  878
36.4  0.6 36.3  0.5
 20)* Group 2 (n  20)† P value
5%) 2 (10%) NS
5%) 3 (15%) NS
0%) 1 (5%) NS
NS
7.0 18.3  8.7
18.9 24.0  32.4
12.5 9.4  12.0
5.3 19.4  6.4 NS
0%) 0 .023
%) 0 NS
0%) 0 NS
%)° 0 NS
%) 0 NS
%) 0 NS
1 (5%) NS
7.4 1.1  0.4 NS
9 9  3 .016
re unit.nasop 1 (n
3 (1
3 (1
2 (1
.4 
.4 
.5 
.7 
5 (2
1 (5
2 (1
1 (5
1 (5
1 (5
0
.2 
15 
sive caThe second patient had a history of chronic obstructive
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tated reintubation at 2 days. The germ was Haemophilus
influenzae. Both patients were discharged at 34 days. The
third patient had occlusive aorta disease and concomitant
ischemic heart and renal artery disease. He was treated for
serious pneumonia that required reintubation 2 days after
extubation. One day later, he presented with septic shock,
and despite resuscitation measures, he subsequently died of
cardiac failure. The identified germs were Haemophilus
influenzae and Escherichia coli. All of these patients be-
longed to the same group (group 1), as did the other
patients with moderate respiratory complications (one
moderate pneumonia and one atelectasis).
Statistical analysis revealed a significant difference be-
tween groups regarding the occurrence of postoperative
respiratory complications (P  .023). Furthermore, com-
pared with patients undergoing early NGT removal, those
with prolonged gastric decompression had a longer hospi-
tal stay (9  3 days vs 15  9 days; P  .016). The stay in
the intensive care unit was also longer in group 1, but the
difference was not significant (4.2  7.4 days vs 1.1 
0.4 days; P  .16).
DISCUSSION
This study was a prospective randomized trial that
compared shortened nasogastric decompression vs routine
nasogastric decompression after open infrarenal aortic sur-
gery. We showed that the resumption of intestinal function
was identical between groups. The incidence of PONV was
not different between the two patient groups, and both
groups were comparable in terms of passage of flatus. It is
interesting to note that we showed a significant difference
between groups regarding postoperative complications,
Bar graph shows the number of patients with first flatus after
operation of the infrarenal aorta at 1, 2, 3, 4, and longer than 4 days
after surgery. No significance could be found between groups.
Solid bars indicate patients with prolonged nasogastric tube main-
tenance; open bars indicate patients with early removal of the
nasogastric tube.with a significant trend toward fewer respiratory complica-tions in the group with early NGT removal. Finally, the
hospital and intensive care unit stays were shorter in the
group with early NGT withdrawal.
This study has several limitations. The main limitation
is the small sample sizes, which do not provide sufficient
statistical power to be conclusive. However, our results are
consistent with those of previous studies5,8 and particularly
with those of a recent meta-analysis.9 Another deficiency
was design faults such as failing to report retroperitoneal
hematoma, hemodynamic instability, or intraoperative vol-
ume overload, which are associated with bowel edema and
consequent ileus.
Several criteria influence the resumption of intestinal
function after elective laparotomy. First, surgical tech-
niques can allow a reduction of bowel mobilization and,
thus, a decreased incidence of ileus. For example, procedures
for aortic surgery—such as minimal incision and retroperito-
neal and, more recently, laparoscopic approaches—can re-
duce bowel manipulation by maintaining it within the
abdominal cavity.10-12 Furthermore, the absence of eviscer-
ation is known to significantly decrease the incidence of
hypothermia and blood loss and, thus, to improve the
postoperative course.13 However, reports are contradictory
regarding the relationship between the duration of the
operative procedure or blood loss and the resumption of
intestinal function.14,15 Other methods have been devel-
oped to reduce postoperative ileus. One study reported that
multimodal rehabilitation for open or laparoscopic colonic
surgery with epidural analgesia, early oral nutrition and
mobilization, and laxative use decreased the duration of
ileus to approximately 2 days.16 In our study, epidural local
anesthetics were avoided. Indeed, we consider that anticoag-
ulant and antiplatelet agents that are commonly prescribed in
patients undergoing operation of the infrarenal aorta could
compromise the safety of epidural catheters related to the
potential occurrence of epidural hematoma.17 Some authors
have noted that rapidly progressing to a liquid diet after the
development of bowel sounds does not foster postoperative
ileus and, thus, have suggested that the duration between
the development of bowel sounds and the start of a liquid
diet was a possible independent predictor of postoperative
ileus.18 Other authors have suggested that early feeding via
the NGT should be performed after surgery to decrease the
need for intravenous solutions and, possibly, to allow ear-
lier discharge.19 However, in a study to define jejunal
manometric and small-bowel transit, the authors predicted
a high rate of enteral feeding intolerance early after surgery
because of impaired function of the jejunum and the small
bowel.15
To assess whether early NGT removal was well toler-
ated and safe, we first looked at the resumption of PONV
with and without early NGT removal. Our study did not
show any significant difference between groups in terms of
PONV. In the single study that evaluated early NGT with-
drawal after aortic surgery, PONV was not among the end
points. In the same study, there was no difference between
groups regarding the resumption of the liquid and solid
diet. The Cheathammeta-analysis of NGT use after elective
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showed that early NGT withdrawal was associated with a
significantly higher rate of vomiting (relative risk, 1.45; P
.005) and of abdominal distension (relative risk, 0.38; P 
.02). However, NGT reinsertion was required in only 5% to
7% of patients, which is similar to our findings. It should be
noted that in this meta-analysis, the duration of postoper-
ative ileus was not among the end points.
Three approaches are recommended to control PONV
symptoms. First, the reduction of PONV risk includes
regional anesthesia, propofol for induction and mainte-
nance of anesthesia, intraoperative supplemental oxygen,
hydration, and minimization of intraoperative and postop-
erative opioids.20 Use of volatile agents was avoided be-
cause they could be the leading cause of early postoperative
vomiting.21,22 Similarly, the maintenance of blood pressure
has been shown to exert an antiemetic effect.23 Second,
antiemetic therapy for PONV prophylaxis can be used. This
type of treatment has considerably changed since the early
1990s with the introduction of new drugs such as sero-
tonin receptor antagonists (specifically the 5-hydroxytryp-
tamine 3 subgroup). Older antiemetics (eg, dexametha-
sone, droperidol, scopolamine, and phenothiazine) are also
effective for preventing PONV; however, some of them are
associated with adverse effects.20 Moreover, multimodal
management that includes antiemetic and specific anes-
thetic regimens seems to be more effective than mono-
therapy prophylaxis.24 Finally, the recommended approach
is to wait and treat only if necessary. Indeed, little evidence
exists for the efficiency of antiemetics for treatment of
established PONV as opposed to prophylaxis.25 Neverthe-
less, there is evidence for the efficiency of 5-hydroxytrypta-
mine 3 receptor antagonists.
Some authors have created scores or models to deter-
mine which patients need antiemetic prophylaxis or ther-
apy. Apfel et al26 created a simplified risk score, identifying
four primary risk factors: female sex, nonsmoking status,
history of PONV, and postoperative opioid use. The inci-
dences of PONVwith the presence of zero, one, two, three,
or all four of these risk factors were approximately
10%, 20%, 40%, 60%, and 80%, respectively. According to
this score, our patients presented one risk factor (postoper-
ative opioid use) in most cases; this corresponds to a 20%
risk. Surprisingly, Apfel et al found that the type of opera-
tion was not an independent risk factor for PONV. Other
studies included as risk factors youth, duration of operation
(each 30-minute increase in duration increases PONV risk
by 60%), type of operation (laparotomy is considered as a
risk factor), and type of anesthesia.27 With this last guide-
line, at least two risk factors (laparoscopy and opioid use)
were present in our patient population, thus leading to a
mild to moderate risk (20%-40%).
We showed a trend toward fewer respiratory complica-
tions in the group with early NGT removal. First, this
finding is consistent with previous reports that have already
shown a higher risk of respiratory complications in the
group with prolonged NGT maintenance.5,28 Second,
although patients could have pre-existing conditions andconcomitant comorbidities, randomized trials ensure bal-
ance in preoperative risk factors between groups. Indeed,
no statistical difference was noted in terms of preoperative
risk factors. In our study, the length of hospitalization
seems to favor early NGT removal. This result is consistent
with previous reports after gastrointestinal surgery in which
the length of hospital stay was shortened by approximately
1 day in the group without early NGT removal.9,18 How-
ever, we may assume that the larger difference observed in
our trial is due in part to the fact that two patients had
severe postoperative complications (the hospital stay was
34 days for both). Finally, a shorter hospital stay probably
reduces hospital costs.
In conclusion, the absence of a significant difference
between groups in terms of resumption of intestinal func-
tion and postoperative complications should encourage
early removal of the NGT. The postoperative course must
include adapted analgesia and medical resuscitation to im-
prove the tolerance of early NGT removal.
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